Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-549,466
Closed -$40.5M – 86
2020
Q2
$40.5M Sell
549,466
-276,882
-34% -$20.8M 0.75% 40
2020
Q1
$60.7M Buy
+826,348
New +$64.9M 1.7% 16
2014
Q1
– Sell
-2,515
Closed -$120K – 63
2013
Q4
$120K Buy
2,515
+524
+26% +$24K 0.01% 56
2013
Q3
$90K Buy
+1,991
New +$90.9K 0.01% 50

Other funds holding MRK

Redmile Group's MRK Position: Q3 2020 in Review

Redmile Group sold out of Merck (MRK) in Q3 2020, closing a stake of 549,466 shares — an estimated $40.5M sold.

Redmile Group first reported a position in MRK in Q3 2013 and held it in 4 quarters. The position peaked at $60.7M in Q1 2020. 2,559 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • Redmile Group reported no remaining Merck position as of Q3 2020 after selling out during the quarter.
  • Redmile Group sold 549,466 Merck shares in Q3 2020, an estimated $40.5M.
  • Redmile Group first reported a position in Merck in Q3 2013 and held it in 4 quarters.
  • Redmile Group's Merck position peaked at $60.7M in Q1 2020.
  • 2,559 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Redmile Group's 13F filing for Q3 2020, filed 16 Nov 2020.